Eugene Schneider - Oct 15, 2021 Form 4 Insider Report for IONIS PHARMACEUTICALS INC (IONS)

Role
EVP, Chf Clinical Develop Offc
Signature
By: Patrick R. O'Neil, attorney-in-fact For: Eugene Schneider
Stock symbol
IONS
Transactions as of
Oct 15, 2021
Transactions value $
-$5,090
Form type
4
Date filed
10/19/2021, 06:29 PM
Previous filing
Apr 19, 2023
Next filing
Jan 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IONS Common Stock Options Exercise $0 +417 +6.04% $0.00 7.32K Oct 15, 2021 Direct F1
transaction IONS Common Stock Tax liability -$5.09K -145 -1.98% $35.10 7.18K Oct 15, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IONS Restricted Stock Unit Options Exercise $0 -417 -1.34% $0.00 30.6K Oct 15, 2021 Common Stock 417 $0.00 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award.
F2 Shares withheld to cover the required tax withholding obligations pursuant to the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan.
F3 Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.
F4 Restricted Stock Units vest in four equal annual installments. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company.